Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.

Zupin, Luisa et al.·Protein and peptide letters·2022·
RPEP-066602022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Human defensins are effective against SARS-CoV-2 and may enhance vaccine responses.

Key Numbers

How They Did This

The study is a review of existing literature on human defensins and their roles in immunity and vaccine enhancement.

Why This Research Matters

Understanding the role of defensins could lead to improved antiviral treatments and more effective vaccines, especially in the context of emerging viruses like SARS-CoV-2.

What This Study Doesn't Tell Us

The study is primarily a literature review and does not include new experimental data.

Trust & Context

Original Title:
Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.
Published In:
Protein and peptide letters, 29(2), 121-124 (2022)
Database ID:
RPEP-06660

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06660·https://rethinkpeptides.com/research/RPEP-06660

APA

Zupin, Luisa; Crovella, Sergio. (2022). Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.. Protein and peptide letters, 29(2), 121-124. https://doi.org/10.2174/0929866528666211125110058

MLA

Zupin, Luisa, et al. "Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.." Protein and peptide letters, 2022. https://doi.org/10.2174/0929866528666211125110058

RethinkPeptides

RethinkPeptides Research Database. "Human Defensins from Antivirals to Vaccine Adjuvants: Redisc..." RPEP-06660. Retrieved from https://rethinkpeptides.com/research/zupin-2022-human-defensins-from-antivirals

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.